Israel News Beep
  • News Beep
  • Israel
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology
Israel News Beep
Israel News Beep
  • News Beep
  • Israel
  • Headlines
  • Business
  • Entertainment
  • Health
  • Science
  • Sports
  • Technology

Browsing Tag

Glucagon-like Peptide-1

15 posts
HHealth
Study: Weight loss with GLP-1 medicines does not result in a disproportionate loss of muscle mass or function in obese mice and humans. Image Credit: Corona Borealis Studio / Shutterstock
Read More

Study finds GLP-1 medicines cut fat while preserving muscle function

  • March 19, 2026
A new study in mice and humans suggests GLP-1 medicines drive weight loss primarily by reducing fat, while…
HHealth
Patients who stop GLP-1 drugs often restart or try alternatives
Read More

Patients who stop GLP-1 drugs often restart or try alternatives

  • March 17, 2026
A large real-world study shows that patients who stop popular GLP-1–based weight-loss drugs often return to treatment or…
HHealth
Study: Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study. Image Credit: Kotcha K / Shutterstock
Read More

Could GLP-1 drugs help curb addiction? Large veteran study points to potential benefit

  • March 9, 2026
A major study of US veterans suggests that GLP-1 diabetes medications may influence addiction-related outcomes, revealing a surprising…
HHealth
Epigenetic editing enables safer and more effective T cell therapies
Read More

Engineered lettuce may turn injectable GLP-1 therapies into oral pills

  • March 7, 2026
Few drugs have entered mainstream awareness as quickly or as dramatically as glucagon-like peptide-1, or GLP-1 receptor agonists.…
HHealth
Review: GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits. Image Credit: Gecko Studio / Shutterstock
Read More

How are GLP-1 drugs reshaping treatment for obesity, diabetes, and heart disease?

  • March 4, 2026
A sweeping Lancet review reveals how modern incretin-based drugs are reshaping treatment for obesity and diabetes, delivering powerful…
TTechnology
Trial: Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial. Image Credit: Alones / Shutterstock
Read More

Combined GLP-1 and GLP-2 treatment appears safe but does not beat placebo for obesity

  • February 25, 2026
Can combining two gut hormone pathways unlock better obesity treatments? In the first human trial of dapiglutide, researchers…
HHealth
Central mechanisms by which peripheral GLP-1RAs may reduce appetite or induce nausea. Peripheral GLP-1 or GLP-1RAs may interact with appetite-regulating regions of the brain via gaps in the blood-brain barrier, via tanycyte uptake, or indirectly via the nodose ganglia. The effects to slow gastric emptying, induce nausea, and reduce energy intake are independent. AgRP, agouti-related peptide; AP, area postrema; ARC, arcuate nucleus; BBB, blood-brain barrier; CART, cocaine- and amphetamine-regulated transcript; H, hypothalamus; lPBN, lateral parabrachial nucleus; NAc, nucleus accumbens; NPY, neuropeptide Y; NTS, nucleus tractus solitarius; POMC, proopiomelanocortin; VTA, ventral tegmental area.
Read More

How GLP-1 drugs affect the body beyond weight loss and glucose control

  • February 19, 2026
Widely used weight-loss and diabetes drugs show clear benefits, but emerging evidence clarifies their side effects, rare risks,…
HHealth
Improving survival in people with severe psychiatric disorders
Read More

Improving survival in people with severe psychiatric disorders

  • January 26, 2026
An expert editorial suggests that widely used diabetes and obesity drugs may help close the long-standing mortality gap…
HHealth
Peroxisomes identified as alternative heat producers in brown fat
Read More

WHO releases first guideline on the use of GLP-1 therapies for treating obesity

  • December 2, 2025
To address the growing global health challenge of obesity, which affects more than 1 billion people, the World Health…
HHealth
Stopping GLP-1 drugs before pregnancy leads to more weight gain
Read More

Stopping GLP-1 drugs before pregnancy leads to more weight gain

  • December 1, 2025
New research shows that women who halt GLP-1 medications near conception face greater gestational weight gain and elevated…
HHealth
Study: Interest in Facial Volume Restorative Procedures With the Rise in “Ozempic Face”: A Google Trends Analysis. Image Credit: Alones / Shutterstock
Read More

Searches for “Ozempic face” surge as people look for filler-based solutions

  • November 21, 2025
New search data reveal that as interest in “Ozempic face” surges, people increasingly turn to nonsurgical fillers rather…
HHealth
AI tool SeeMe detects hidden signs of consciousness in brain injury patients
Read More

Tirzepatide may only temporarily suppress brain activity involved in “food noise”

  • November 18, 2025
A rare glimpse into the brain activity of a patient with obesity and loss of control eating on…
Israel News Beep
www.newsbeep.com